Journals / Klinik Psikofarmakoloji Bülteni / 2007 / Cilt: 17 - Sayı: 3

Apathy due to colloid cyst operation treated with bromocriptine: a case report

Kolloid kist operasyonuna bağlı apatinin bromokriptin ile tedavisi: Bir olgu sunumu

Pages
138–141
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Apathy symptoms were treated by gradually increasing bromocriptine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Apathy is characterised by clinically significant decrease in goal directed act, due to lack of motivation.
📊
Key Findings & Data:Treatment resistant obsessive compulsive syndrome and apathy symptoms were emerged after the operation of colloid cycstectomy in a 44 years old female patient.
💡
Conclusion & Impact:Apathy symptoms were treated by gradually increasing bromocriptine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Apathy is characterised by clinically significant decrease in goal directed act, due to lack of motivation. Apathy could be seen both as a symptom of other syndromes or as a syndrome per se. It has been reported that, apathy is caused by affected especially frontal and basal fore brain systems. Neuropharmacology of apathy is very complicated and many neurotransmitters and neuro-modulators can play a part in apathy. Dopaminergic drugs like amantadine, amphetamine, bupropion, methylphenidate, levodopa/carbidopa have been used in the treatment of apathy. In this case report, treatment of apathy due to colloid cyst operation with bromocriptine is presented. Treatment resistant obsessive compulsive syndrome and apathy symptoms were emerged after the operation of colloid cycstectomy in a 44 years old female patient. Although obssesive compulsive disorder was treated; there was not any change in apathy symptoms. Apathy symptoms were treated by gradually increasing bromocriptine.

Özet

Apati, motivasyon kaybına bağlı olarak amaca yönelik eylemlerin anlamlı ölçüde azalmasıdır. Bir semptom ya da bir sendrom olarak gözlenebilir. Özellikle frontal bölge ve bazal ön beyin sistemlerindeki etkilenmelerden sonra ortaya çıktığı belirtilmektedir. Apatinin nörofarmakolojisi oldukça karmaşık olup ortaya çıkışında birçok nörotransmitter ve nöromodülatörün rol oynadığı düşünülmektedir. Tedavisinde ise amantadin, amfetamin, bupropion, bromokriptin, metilfenidat, levodopa/ karbidopa gibi dopaminerjik ilaçlar kullanılmaktadır. Bu yazıda beynin 3. ventrikülündeki kolloid kistin opere edilmesine bağlı olarak ortaya çıkan bir apati olgusunun bromokriptin ile tedavisi sunulmuştur. Kırk dört yaşında olan bir kadın hastada, operasyon sonrasında tedaviye dirençli obsesif kompulsif bozukluk ve apati belirtileri ortaya çıkmıştır.Obsesif kompulsif bozukluğun tedavi edilmesine karşın; apati belirtilerinde değişiklik olmamıştır. Apati belirtileri bromokroptin başlanması ve kademeli olarak artırılması ile tedavi edilmiştir.

🔖

Cite This Article

ULAŞ, H., TUNCA, Z., YILDIZ, A. (2022). Apathy due to colloid cyst operation treated with bromocriptine: a case report. Klinik Psikofarmakoloji Bülteni, Cilt: 17 - Sayı: 3, 138–141. https://ajindex.com/articles/574364

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Marin RS. Differential diagnosis of apathy and related disorders of diminished motivation. Psychiatric Annals 1997; 27:30-33 2. Cummings, JL. Concise guide to neuropsychiatry and behavioral neurology. Washington DC: American Psychiatry Publishing, 2002 3. Marin RS. Apathy: concept, syndrome, neural mechanisms and treatment. Seminars in Clinical Neuropsychiatry 1996; 1:304-314 4. Reekum R., Stuss DT, Ostrander L. Apathy: Why care? The Journal of Neuropsychiatry and Clinical Neurosciences 2005; 17:7-19 5. Starkstein SE, Petracca G, Chemerinski E, et al. Syndromic validitiy of apathy in Alzheimer’s disease. American Journal of Psychiatry 2001; 158: 872-877 6. Starkstein SE, Mayberg HS, Preziosi TJ, et al. Reliability, validity and clinical correlates of apathy in Parkinson’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences 1992; 4:134-139 7. Amerikan Psikiyatri Birliği Mental Bozuklukların Tanısal ve Sayım Elkitabı, Dördüncü baskı (DSM IV), Köroğlu E (çeviren), Hekimler Yayın Birliği, Ankara, 1994 8. Duffy MB, Ravi K. Apathy secondary to neurologic disease. Psychiatric Annals 1997; 27:39-42 9. James D. The neural substrates of motivation. Psychiatric Annals 1997; 27:24-27 10. Campell JJ, Duffy JD. Treatment strategies in Amotivated Patients. Psychiatric Annals 1997; 27:44-48 11. Marin, RS. and Wilkosz PA. Disorders of diminished motivation. Journal of Head Trauma Rehabilitation 2005; 20(4): 377-388 12. Akdemir A, Turkcapar MH, Orsel SD. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Comprehensive Psychiatry 2001; 42:161-165 13. Kayatekin MS, Öztürk MD, Savaşır I. Kısa Kognitif Muayene (KKM) çizelgesinin güvenilirlik ve geçerlilik çalışmaları. Düşünen Adam 1986; 1:63-66 14. Marin RS, Biedrzycki RC, Firincio¤ullar› S. Reliability and validity of Apathy Evaluation Scale. Psychiatry Research 1991; 38:143-162 15. Kwon JS, Kim JJ, Lee DW. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 2003; 122: 37-47 16. Powell JH, Adawi S, Morgan J, Greenwood RJ. Motivational deficits after brain injury: effects of bromocriptine in 11 patients. The Journal of Neuropsychiatry and Clinical Neurosciences 1996; 60: 416-421